TY - JOUR
T1 - Cancer Patients during COVID-19 Pandemic
T2 - A Mini-Review
AU - Linjawi, Maryam
AU - Shakoor, Hira
AU - Hilary, Serene
AU - Ali, Habiba I.
AU - Al-Dhaheri, Ayesha S.
AU - Ismail, Leila Cheikh
AU - Apostolopoulos, Vasso
AU - Stojanovska, Lily
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/1
Y1 - 2023/1
N2 - Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and healthcare workers in hospitals affect cancer care. This paper includes a description of the existing research that shows the impact of COVID-19 on the management of cancer patients. Aged people with various chronic conditions such as cancer and comorbidities face more challenges as they have a greater risk of disease severity. COVID-19 has affected care delivery, including patient management, and has been responsible for increased mortality among cancer patients. Cancer patients with severe symptoms require regular therapies and treatment; therefore, they have a higher risk of exposure. Due to the risk of transmission, various steps were taken to combat this disease; however, they have affected the existing operational efficiency. Herein, we present the changing priorities during COVID-19, which also affected cancer care, including delayed diagnosis, treatment, and surgeries.
AB - Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and healthcare workers in hospitals affect cancer care. This paper includes a description of the existing research that shows the impact of COVID-19 on the management of cancer patients. Aged people with various chronic conditions such as cancer and comorbidities face more challenges as they have a greater risk of disease severity. COVID-19 has affected care delivery, including patient management, and has been responsible for increased mortality among cancer patients. Cancer patients with severe symptoms require regular therapies and treatment; therefore, they have a higher risk of exposure. Due to the risk of transmission, various steps were taken to combat this disease; however, they have affected the existing operational efficiency. Herein, we present the changing priorities during COVID-19, which also affected cancer care, including delayed diagnosis, treatment, and surgeries.
KW - COVID-19
KW - cancer
KW - immunity
KW - patient care
KW - vaccine
UR - http://www.scopus.com/inward/record.url?scp=85146764143&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146764143&partnerID=8YFLogxK
U2 - 10.3390/healthcare11020248
DO - 10.3390/healthcare11020248
M3 - Review article
AN - SCOPUS:85146764143
SN - 2227-9032
VL - 11
JO - Healthcare (Switzerland)
JF - Healthcare (Switzerland)
IS - 2
M1 - 248
ER -